Lamdong Pharmaceutical JSC (HNX:LDP)

HNX:LDP Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	16,766	18,614	11,451	16,205	16,619	65,159
Short-Term Investments	-	2,215	3,014	2,896	1,788	-
Trading Asset Securities	10,000	-	2,692	1,121	-	-
Cash & Short-Term Investments	26,767	20,829	17,157	20,222	18,407	65,159
Cash Growth	25.87%	21.40%	-15.15%	9.86%	-71.75%	130.59%
Accounts Receivable	39,795	44,699	27,466	21,535	21,415	23,286
Other Receivables	3,807	750.84	1,207	1,238	10,819	432.72
Receivables	43,602	53,450	36,673	30,773	32,234	23,719
Inventory	68,790	55,422	48,962	37,751	55,919	54,575
Prepaid Expenses	1,377	1,864	2,076	220.82	957.04	284.73
Other Current Assets	120,365	118,935	51,865	51,026	51,458	545.85
Total Current Assets	260,900	250,500	156,733	139,993	158,976	144,283
Property, Plant & Equipment	37,612	38,655	42,555	46,329	55,742	60,718
Other Intangible Assets	-	-	68.6	229.47	491.92	740.21
Long-Term Accounts Receivable	9,300	9,300	-	-	-	-
Other Long-Term Assets	9,092	9,306	7,800	8,221	13,164	10,180
Total Assets	316,904	307,760	207,157	194,773	228,374	215,921

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	30,752	30,970	31,545	23,549	31,801	13,964
Accrued Expenses	24,928	22,086	16,705	8,887	7,216	3,345
Short-Term Debt	62,192	56,974	55,026	65,368	70,298	29,960
Current Portion of Long-Term Debt	-	-	-	591.64	-	-
Current Income Taxes Payable	-	-	-	157.19	1,063	7,209
Current Unearned Revenue	66	134.18	134.18	-	60	72
Other Current Liabilities	3,940	4,321	2,692	2,134	3,138	3,933
Total Current Liabilities	121,878	114,485	106,103	100,687	113,574	58,483
Long-Term Debt	-	-	-	-	591.64	2,339
Other Long-Term Liabilities	1,770	1,780	1,770	1,720	1,720	1,720
Total Liabilities	123,647	116,265	107,873	102,407	115,886	62,541

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	187,282	187,282	127,032	127,032	127,032	127,032
Additional Paid-In Capital	4,203	4,203	-	-	-	-
Retained Earnings	1,772	10.89	-27,747	-34,666	-14,543	26,348
Treasury Stock	-0.32	-0.32	-0.32	-0.32	-0.32	-0.32
Shareholders' Equity	193,257	191,496	99,284	92,366	112,489	153,380
Total Liabilities & Equity	316,904	307,760	207,157	194,773	228,374	215,921

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	62,192	56,974	55,026	65,960	70,889	32,299
Net Cash (Debt)	-35,425	-36,145	-37,869	-45,738	-52,482	32,860
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-2112.13	-2569.07	-2981.06	-3600.54	-4132.07	2586.61
Filing Date Shares Outstanding	18.77	18.73	12.7	12.7	12.7	12.7
Total Common Shares Outstanding	18.77	18.73	12.7	12.7	12.7	12.7
Working Capital	139,022	136,015	50,630	39,305	45,402	85,800
Book Value Per Share	10298.16	10225.02	7815.75	7271.08	8855.18	12073.06
Tangible Book Value	193,257	191,496	99,216	92,136	111,997	152,640
Tangible Book Value Per Share	10298.16	10225.02	7810.35	7253.02	8816.45	12014.79
Buildings	-	62,465	62,604	62,903	-	-
Machinery	-	37,950	61,717	62,170	-	-
Construction In Progress	3,876	2,995	2,851	-	690.2	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 10, 2026

Data Sources Report a data error